Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: Impact of bilharziasis and fibrosis stage


Creative Commons License

DERBALA M. F. , AL KAABI S. R. , EL DWEIK N. Z. , PASIC F., BUTT M. T. , YAKOOB R., ...Daha Fazla

WORLD JOURNAL OF GASTROENTEROLOGY, cilt.12, sa.35, ss.5692-5698, 2006 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Konu: 35
  • Basım Tarihi: 2006
  • Doi Numarası: 10.3748/wjg.v12.i35.5692
  • Dergi Adı: WORLD JOURNAL OF GASTROENTEROLOGY
  • Sayfa Sayıları: ss.5692-5698

Özet

AIM: To evaluate pegylated interferon alpha2a (PegIFN-alpha 2a) in Egyptian patients with HCV genotype 4, and the impact of pretreatment viral load, co-existent bilharziasis and histological liver changes on response rate.